 Stem Cell Culture |
ImmuneRegen BioSciences announced the results of a bone marrow study involving Homspera. Results point to the ability of Homspera to enhance formation of early-stage blood cells from adult hematopoietic (blood-forming) stem cells. The studies, performed by University of Medicine and Dentistry of New Jersey (UMDNJ) Professor Pranela Rameshwar, PhD, not only were consistent with previous stem cell study results, but also demonstrated the potency of Homspera.
Rameshwar compared Homspera to Substance P, a peptide found naturally in the body, which is a known stimulant of hematopoiesis. The data indicated Homspera was more effective than Substance P at stimulating hematopoiesis. This impact on the production of blood cells suggests the possibility that Homspera may have clinical application in strengthening the human immune system.
This article was published in Drug Discovery & Development magazine: Vol. 11, No. 5, May, 2008, pp. 30.
Filed Under: Drug Discovery
